Second Patient Dies After Gene Therapy for Duchenne Muscular...

Compartió un vínculo

2025-06-17 15:00:07

Second Patient Dies After Gene Therapy for Duchenne Muscular Dystrophy: Company

Sarepta, the company that makes the drug, is pausing it for non-ambulatory patients.A second patient has died after receiving the gene therapy Elevidys, which was approved by the Food and Drug Administration

0 Commentarios 0 Acciones 38 Views